Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 237
9
Diseases
7
Unique genes
0.343
Avg. similarity score
Childhood myocerebrohepatopathy spectrum
Most-connected disease (7 links)
Disease
Searched: Fanconi anemia complementation group i
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Fanconi anemia complementation group i
Childhood myocerebrohepatopathy spectrum
Mitochondrial recessive ataxia syndrome (includes sando and scae)
Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive, 1
Schilder disease
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
Mitochondrial hepatopathy
Neonatal convulsions
Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Childhood myocerebrohepatopathy spectrum | 7 | 7 | 1 |
| Mitochondrial recessive ataxia syndrome (includes sando and scae) | 7 | 7 | 1 |
| Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive, 1 | 7 | 7 | 1 |
| Schilder disease | 7 | 7 | 1 |
| Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | 6 | 6 | 5 |
| Mitochondrial hepatopathy | 5 | 5 | 3 |
| Neonatal convulsions | 5 | 5 | 3 |
| Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1 | 5 | 5 | 1 |
| Fanconi anemia complementation group i | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| POLG | 8 / 9 | Childhood myocerebrohepatopathy spectrum, Mitochondrial hepatopathy, Mitochondrial recessive ataxia syndrome (includes sando and scae), Neonatal convulsions and 4 more |
| FANCI | 2 / 9 | Fanconi anemia complementation group i, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
| POLGARF | 2 / 9 | Mitochondrial hepatopathy, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
| TWNK | 2 / 9 | Mitochondrial hepatopathy, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Choline catabolism | Reactome | 1 / 6 | 286× | 3.49e-3 | 2.83e-2 ✓ sig. |
| Lysine catabolism | Reactome | 1 / 12 | 143× | 6.97e-3 | 4.53e-2 ✓ sig. |
| ERBB2 Regulates Cell Motility | Reactome | 1 / 15 | 114× | 8.71e-3 | 5.22e-2 |
| Histidine metabolism | KEGG | 1 / 22 | 78.0× | 1.28e-2 | 6.57e-2 |
| Ascorbate and aldarate metabolism | KEGG | 1 / 30 | 57.2× | 1.74e-2 | 7.88e-2 |
| beta-Alanine metabolism | KEGG | 1 / 31 | 55.3× | 1.79e-2 | 8.05e-2 |
| One carbon pool by folate | KEGG | 1 / 38 | 45.2× | 2.19e-2 | 9.03e-2 |
| Glycine, serine and threonine metabolism | KEGG | 1 / 40 | 42.9× | 2.31e-2 | 9.30e-2 |
| Fanconi Anemia Pathway | Reactome | 1 / 40 | 42.9× | 2.31e-2 | 9.30e-2 |
| Tryptophan metabolism | KEGG | 1 / 42 | 40.9× | 2.42e-2 | 9.58e-2 |
| Fatty acid degradation | KEGG | 1 / 43 | 39.9× | 2.48e-2 | 9.69e-2 |
| Base excision repair | KEGG | 1 / 44 | 39.0× | 2.54e-2 | 9.82e-2 |
| Pyruvate metabolism | KEGG | 1 / 47 | 36.5× | 2.71e-2 | 1.02e-1 |
| Valine, leucine and isoleucine degradation | KEGG | 1 / 48 | 35.7× | 2.77e-2 | 1.03e-1 |
| Arginine and proline metabolism | KEGG | 1 / 50 | 34.3× | 2.88e-2 | 1.06e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mitochondrial DNA replication | GO:0006264 | 2 / 11 | 485× | 6.60e-6 | 3.94e-4 ✓ sig. |
| DNA-templated DNA replication | GO:0006261 | 2 / 41 | 130× | 9.79e-5 | 3.04e-3 ✓ sig. |
| glycine betaine biosynthetic process from choline | GO:0019285 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| DNA replication | GO:0006260 | 2 / 131 | 40.8× | 1.00e-3 | 1.46e-2 ✓ sig. |
| DNA replication proofreading | GO:0045004 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| choline catabolic process | GO:0042426 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| sensory perception of sound | GO:0007605 | 2 / 162 | 33.0× | 1.52e-3 | 1.85e-2 ✓ sig. |
| protein localization to axon | GO:0099612 | 1 / 5 | 534× | 1.87e-3 | 2.05e-2 ✓ sig. |
| cellular response to histamine | GO:0071420 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| mitochondrial transcription | GO:0006390 | 1 / 8 | 334× | 2.99e-3 | 2.59e-2 ✓ sig. |
| protein localization to microtubule | GO:0035372 | 1 / 10 | 267× | 3.74e-3 | 2.90e-2 ✓ sig. |
| protein hexamerization | GO:0034214 | 1 / 12 | 222× | 4.49e-3 | 3.17e-2 ✓ sig. |
| aldehyde metabolic process | GO:0006081 | 1 / 13 | 205× | 4.86e-3 | 3.29e-2 ✓ sig. |
| regulation of microtubule-based process | GO:0032886 | 1 / 13 | 205× | 4.86e-3 | 3.29e-2 ✓ sig. |
| base-excision repair, gap-filling | GO:0006287 | 1 / 14 | 191× | 5.23e-3 | 3.41e-2 ✓ sig. |